pI: 6.622 |
Length (AA): 136 |
MW (Da): 15318 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 133 | 3e0m (A) | 163 | 294 | 39.00 | 0 | 1 | 1.54774 | -1.05 |
4 | 132 | 3cxk (A) | 10 | 137 | 48.00 | 0 | 1 | 1.62923 | -1.1 |
5 | 133 | 2k8d (A) | 23 | 149 | 58.00 | 0 | 1 | 1.60833 | 0.05 |
7 | 133 | 3hcg (A) | 380 | 505 | 41.00 | 0 | 1 | 1.55952 | -1.25 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | murphy |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Dormant phase. | hasan |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
Ortholog group members (OG5_127019)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G21830 | peptide methionine sulfoxide reductase B7 |
Arabidopsis thaliana | AT4G04800 | peptide methionine sulfoxide reductase B3 |
Arabidopsis thaliana | AT4G04810 | peptide methionine sulfoxide reductase B4 |
Arabidopsis thaliana | AT4G21840 | methionine sulfoxide reductase B8 |
Arabidopsis thaliana | AT4G21860 | peptide methionine sulfoxide reductase B2 |
Arabidopsis thaliana | AT4G04830 | peptide methionine sulfoxide reductase B5 |
Arabidopsis thaliana | AT1G53670 | peptide methionine sulfoxide reductase B1 |
Arabidopsis thaliana | AT4G21850 | methionine sulfoxide reductase B9 |
Arabidopsis thaliana | AT4G04840 | methionine sulfoxide reductase B6 |
Brugia malayi | Bm1_44650 | peptide methionine sulfoxide reductase msrB |
Candida albicans | CaO19.3292 | similar to S. cerevisiae orf YCL033C |
Candida albicans | CaO19.10802 | similar to S. cerevisiae orf YCL033C |
Caenorhabditis elegans | CELE_F44E2.6 | Protein F44E2.6, isoform B |
Dictyostelium discoideum | DDB_G0291145 | hypothetical protein |
Drosophila melanogaster | Dmel_CG6584 | Selenoprotein R |
Escherichia coli | b1778 | methionine sulfoxide reductase B |
Echinococcus granulosus | EgrG_000840900 | peptide methionine sulfoxide reductase |
Echinococcus multilocularis | EmuJ_000840900 | peptide methionine sulfoxide reductase |
Giardia lamblia | GL50803_5180 | Peptide methionine sulfoxide reductase msrB |
Homo sapiens | ENSG00000174099 | methionine sulfoxide reductase B3 |
Homo sapiens | ENSG00000148450 | methionine sulfoxide reductase B2 |
Leishmania braziliensis | LbrM.28.2870 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_282860.1 | SelR domain containing protein, putative |
Leishmania infantum | LinJ.28.2860 | hypothetical protein, conserved |
Leishmania major | LmjF.28.2660 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.28.2660 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_00565 | peptide methionine sulfoxide reductase msrB |
Mus musculus | ENSMUSG00000051236 | methionine sulfoxide reductase B3 |
Mus musculus | ENSMUSG00000023094 | methionine sulfoxide reductase B2 |
Mycobacterium tuberculosis | Rv2674 | Probable peptide methionine sulfoxide reductase MsrB (protein-methionine-R-oxide reductase) (peptide met(O) reductase) |
Mycobacterium ulcerans | MUL_3308 | hypothetical protein |
Neospora caninum | NCLIV_057200 | AT4G21860 protein, related |
Oryza sativa | 4341018 | Os06g0472000 |
Oryza sativa | 4338744 | Os05g0404200 |
Oryza sativa | 4332888 | Os03g0360700 |
Saccharomyces cerevisiae | YCL033C | Mxr2p |
Schistosoma japonicum | Sjp_0306390 | ko:K07304 peptide-methionine (S)-S-oxide reductase [EC1.8.4.11], putative |
Schistosoma japonicum | Sjp_0203880 | ko:K07305 peptide-methionine (R)-S-oxide reductase [EC1.8.4.12], putative |
Schistosoma mansoni | Smp_167890.1 | methionine sulfoxide reductase B2b |
Schistosoma mansoni | Smp_143340 | methionine sulfoxide reductase |
Schistosoma mansoni | Smp_167890.2 | methionine sulfoxide reductase B2b |
Schmidtea mediterranea | mk4.014965.00 | Methionine-R-sulfoxide reductase B2, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.11.13390 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.11930 | SelR domain containing protein, putative |
Trypanosoma congolense | TcIL3000.11.12590 | SelR domain containing protein, putative |
Trypanosoma cruzi | TcCLB.511211.49 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_314000 | peptide methionine sulfoxide reductase msrB, putative |
Trichomonas vaginalis | TVAG_156810 | methionine sulfoxide reductase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2720 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.01.3760 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.3760 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.3760 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.3760 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_314000 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.